Today: 23 May 2026
Browse Category

NYSE:LLY 28 September 2025 - 6 November 2025

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Pops as White House Strikes Obesity-Drug Pricing Deal; New 20% Weight‑Loss Data Fuels Momentum — Today, November 6, 2025

Eli Lilly shares rose midday, trading near $935.89, after the White House announced expanded Medicare coverage and lower prices for obesity drugs, including Zepbound. New Phase 2 data showed Lilly’s eloralintide led to up to 20.1% weight loss, with Phase 3 trials set for December 2025. BMO Capital raised its price target to $1,100.
6 November 2025
·
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk’s Weight-Loss Drug Boom Hits a Wall – Wegovy Slowdown Sparks Stock Slump and Forecast Cut

Novo Nordisk cut its 2025 sales and profit outlook for the fourth time this year after third-quarter results missed forecasts, with Wegovy revenues below expectations. Operating profit fell 30% due to restructuring costs. The company faces rising competition from Eli Lilly and U.S. copycat drugs, as well as mounting pricing pressure. Shares have dropped up to 50% in 2025; Novo plans 9,000 job cuts and a $10 billion bid for Metsera.
5 November 2025
···
Luxury Boom vs. Fed Gloom: European Markets Whipsaw (Sept 23–24, 2025)

5 Stocks You Need to Buy Now (November 4, 2025) – Tech, Energy, Biotech & More

Amazon reported record Q3 earnings with revenue up 13% year-over-year, pushing its market cap to $2.6 trillion. JPMorgan Chase beat profit estimates, posting Q3 EPS of $5.07 and trading near all-time highs. Eli Lilly’s Q3 sales jumped 54% to $17.6 billion on strong obesity drug demand. Exxon Mobil raised its dividend after record output, while Alibaba’s stock climbed on 8% sales growth and rapid AI expansion.
4 November 2025
····
Eli Lilly Stock Pre-Market Preview: Will Obesity-Drug Boom Send LLY to New Highs? (Nov 3, 2025)

Eli Lilly Stock Pre-Market Preview: Will Obesity-Drug Boom Send LLY to New Highs? (Nov 3, 2025)

Eli Lilly shares closed near $863 on Oct. 31, up about 10% for the month and close to a 52-week high. Q3 revenue jumped 54% to $17.6 billion, driven by surging demand for GLP-1 drugs Mounjaro and Zepbound, with U.S. GLP-1 market share at 57%. Management raised 2025 sales and EPS guidance sharply. The company recently won FDA approval for Inluriyo and expanded Walmart access for Zepbound.
2 November 2025
·
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

Eli Lilly reported Q3 2025 revenue of $17.60 billion, up 54% year-over-year, and raised full-year EPS guidance to $23.00–23.70. Shares closed at $813.53 on Oct. 29, down 2% over the week after hitting highs above $850 earlier in the month. The FDA approved Inluriyo for metastatic breast cancer, and the EU cleared Kisunla for early Alzheimer’s. Wall Street’s average 12-month price target stands near $939.
30 October 2025
···
Pharma Giants Converge in Frankfurt – Obesity Drug Boom & Tech Innovations Fuel $1.7 Trillion Industry Future

Pharma Giants Converge in Frankfurt – Obesity Drug Boom & Tech Innovations Fuel $1.7 Trillion Industry Future

Over 62,000 pharmaceutical professionals from more than 170 countries are attending CPHI Frankfurt 2025, where executives are meeting to address global supply chain, regulation, and innovation challenges. Eli Lilly’s GLP-1 drugs generated $6.1 billion in Q1 2025, overtaking Novo Nordisk in the U.S. weight-loss drug market. Pharma giants are investing heavily as the global obesity treatment market is projected to reach $100 billion by 2030.
28 October 2025
····
Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Eli Lilly said Oct. 24 it will buy Adverum Biotechnologies for $3.56 per share plus a CVR worth up to $8.91, targeting Adverum’s lead gene therapy Ixo-vec for wet AMD. Adverum shares jumped 17% on the news but stayed well below the $12.47 maximum deal value. The agreement includes a $65 million secured loan to fund trials before closing. Adverum had warned its cash would run out by Q4 2025.
24 October 2025
···
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics shares jumped 17% to $30.35 on Oct. 20, 2025, marking their highest level since early 2024. The rally followed bullish technical signals and positive clinical updates for its gene-editing therapies. Analysts at Jefferies and H.C. Wainwright reiterated Buy ratings, with price targets up to $80. Beam ended Q2 with $1.2 billion in cash, enough to fund operations into 2028.
20 October 2025
·····
Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

The Nasdaq closed at 22,679.98 Friday, up 117 points, capping a volatile week near record highs. Nvidia shares retreated after hitting records, while AMD jumped 34% on an OpenAI chip deal. The KBW Regional Bank Index rebounded after sharp losses as banks addressed loan and fraud concerns. The VIX spiked to a six-month high before easing, with traders bracing for volatility ahead of major tech earnings and a delayed U.S. inflation report.
18 October 2025
·········
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Surges on Obesity Drug Boom and Alzheimer’s Breakthroughs – Is $1,000 Next?

Eli Lilly shares hit a record $832 intraday on Oct. 1, fueled by demand for its obesity drugs and Alzheimer’s advances, before slipping 4% after Donald Trump pledged to cut weight-loss drug prices. Lilly’s Mounjaro and ZepBound now hold 57% of U.S. GLP-1 prescriptions, outpacing Novo Nordisk. First-half 2025 revenue jumped about 40% year-on-year. Most analysts remain bullish, despite valuation and policy concerns.
17 October 2025
··
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Rockets on GLP‑1 Boom and New Approvals: Is LLY the Next Trillion‑Dollar Pharma Titan?

Eli Lilly stock opened at $840.46 on Oct. 6, 2025, after a 9% surge the previous week, with a market cap near $795 billion and P/E ratio around 55. Q2 revenue rose 38% to $15.56 billion, led by Mounjaro and Zepbound, and Lilly raised 2025 guidance to $60–62 billion revenue. The company announced over $1 billion investment in India manufacturing and received European approval for Kisunla in early Alzheimer’s.
6 October 2025
·
Shutdown Drags On But Wall Street Hits Records – Here’s What’s Driving Markets

Shutdown Drags On But Wall Street Hits Records – Here’s What’s Driving Markets

The S&P 500 and Dow closed at record highs despite a second week of U.S. government shutdown, while the Nasdaq lagged as tech shares wavered. Key economic data releases were delayed, forcing traders to rely on private surveys showing continued labor market weakness. Markets expect the Federal Reserve to cut rates in October. Japan’s Nikkei hit a record after a pro-stimulus leader’s election, and gold reached $3,944 an ounce.
6 October 2025
····
Bitcoin Blasts Past $125K, AI Wars Escalate, and Space Tech Soars – Global Tech Roundup (Oct 5–6, 2025)

Bitcoin Blasts Past $125K, AI Wars Escalate, and Space Tech Soars – Global Tech Roundup (Oct 5–6, 2025)

Bitcoin surged past $125,000 to a record high as investors poured in. Elon Musk’s xAI and OpenAI filed lawsuits against each other, with OpenAI calling Musk’s claims “harassment.” Tesla teased an Oct. 7 event for a cheaper electric car. Firefly Aerospace agreed to buy defense firm SciTec for $855 million to expand military space work.
6 October 2025
··········
U.S. Stocks Rally as Shutdown Fears Fade – Markets Hit Fresh Records

U.S. Stocks Rally as Shutdown Fears Fade – Markets Hit Fresh Records

All three major U.S. indexes closed at record highs on Oct. 1, with the S&P 500 topping 6,700 for the first time. ADP reported U.S. private payrolls fell by 32,000 in September, fueling bets on two Fed rate cuts by year-end. The 10-year Treasury yield dropped to 4.10%, gold hit a record near $3,895, and healthcare stocks surged after a Trump–Pfizer price deal. Lithium Americas soared 23% after a U.S. government investment.
2 October 2025
······
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

The Federal Reserve cut rates by 25 basis points to 4.00–4.25% in mid-September, citing slowing growth as inflation remains above target. The S&P 500 is up about 13% in 2025, but strategists warn valuations are high. Compass agreed to buy Anywhere for $4.2 billion in stock, sending Anywhere shares up nearly 49%. The U.S. implemented a new auto trade pact with the EU, lowering tariffs to 15% as of August 1.
28 September 2025
·············
1 … 9 10 11 12

Stock Market Today

  • Queen Mary Highlights Tasmanian Biodiversity Loss on Royal Visit
    May 23, 2026, 4:39 AM EDT. Queen Mary marked Biodiversity Day by sharing photos from her childhood street in Tasmania, spotlighting the region's rich but vulnerable seaweed forests. These dense underwater forests support hundreds of species but have lost 95% coverage due to ocean warming. The University of Tasmania is actively restoring this ecosystem through innovative projects involving sea urchin management and indigenous collaboration. This local conservation effort, emphasized during Queen Mary's March visit with King Frederik, underscores the global importance of protecting unique coldwater biodiversity. Queen Mary expressed pride in her Tasmanian roots during their first official visit to the area since 2005, highlighting the critical connection between local action and broader environmental benefits.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 23.05.2026

23 May 2026
LIVEMarkets rolling coverageStarted: May 23, 2026, 4:00 AM EDTUpdated: May 23, 2026, 4:40 AM EDT Queen Mary Highlights Tasmanian Biodiversity Loss on Royal Visit May 23, 2026, 4:39 AM EDT. Queen Mary marked Biodiversity Day by sharing photos from her childhood street in Tasmania, spotlighting the region’s rich but vulnerable seaweed forests. These dense underwater forests support hundreds of species but have lost 95% coverage due to ocean warming. The University of Tasmania is actively restoring this ecosystem through innovative projects involving sea urchin management and indigenous collaboration. This local conservation effort, emphasized during Queen Mary’s March visit with King
Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
Go toTop